Linda J.W. Bosch

Identification of the optimal combination dosing schedule of neoadjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma (OpACIN-neo): a multicentre, phase 2, randomised, controlled trial

Elisa A. Rozeman, Alexander M. Menzies, Alexander C. J. van Akkooi et al. · The Lancet Oncology · 2019 · 498 citations

Oncology, Medicine, Melanoma +6

Multitarget Stool DNA Test Performance in an Average-Risk Colorectal Cancer Screening Population

Linda J.W. Bosch, Veerle Melotte, Sandra Mongera et al. · The American Journal of Gastroenterology · 2019 · 90 citations · Full text

Consensus molecular subtype classification of colorectal adenomas

Malgorzata A. Komor, Linda J.W. Bosch, Gergana Bounova et al. · The Journal of Pathology · 2018 · 84 citations · Full text

IFN-γ signature enables selection of neoadjuvant treatment in patients with stage III melanoma

Irene L. M. Reijers, Disha Rao, Judith M. Versluis et al. · The Journal of Experimental Medicine · 2023 · 70 citations · Full text

Cancer Immunosurveillance, Medicine, Donimi Trial +15

Genomic landscape of metastatic colorectal cancer

Josien Haan, Mariëtte Labots, Christian Rausch et al. · Nature Communications · 2014 · 67 citations · Full text

Pathology, Tumor Biology, Gastrointestinal Oncology +17